PPARδ agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-09-19. Where a claim depends on a specific study, the study is described rather than over-claimed.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
| Property | Value | Notes |
|---|---|---|
| Chemical class | PPARδ agonist | Not an anabolic steroid. |
| Common synonyms | GW501516, GW-1516 | Cardarine is an informal name. |
| Appearance | White to off-white powder | Typical for research-grade solid. |
| Solubility class | Poorly soluble in water; soluble in some organic solvents | Such as DMSO or ethanol in laboratory settings. |
| Typical storage temperature | Cool, dry, protected from light | Specific conditions vary by supplier and form. |
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
== External links == Media related to Earthworms at Wikimedia Commons Data related to Lumbricina at Wikispecies Chisholm, Hugh, ed. (1911). "Earthworm" . Encyclopædia Britannica (11th ed.). Cambridge University Press.
Dehydrogenase and oxidase are easily distinguishable if one considers the electron acceptor. An oxidase will remove electrons from a substrate as well, but only uses oxygen as its electron acceptor. One such reaction is: AH2 + O2 ↔ A + H2O2. Sometimes an oxidase reaction will look like this: 4A + 4H+ + O2 ↔ 4A+ + 2H2O. In this case, the enzyme is taking electrons from the substrate, and using free protons to reduce the oxygen, leaving the substrate with a positive charge. The product is water, instead of hydrogen peroxide as seen above. An example of an oxidase that functions like this is complex IV in the Electron Transport Chain (ETC). Note that oxidases typically transfer the equivalent of dihydrogen (H2), and the acceptor is a dioxygen. Similarly, a peroxidase (another subclass of oxidoreductases) will use a peroxide (H2O2) as the electron acceptor, rather than an oxygen.
Because these two ions are at the end of Hofmeister series, ammonium sulfate can also stabilize a protein structure. The ammonium sulfate solubility behavior for a protein is usually expressed as a function of the percentage of saturation. A solubility curve can be determined by plotting the log of the experimentally determined solubility, expressed as mg/mL, versus the percentage saturation of ammonium sulfate. With the mechanism of salting-out, there is an omission of the salt from the layer of water, which is closely associated with the surface of the protein, known as the hydration layer. The hydration layer plays a vital role in sustaining solubility and suitable natural conformation. There are three main protein-water interaction: ion hydration between charged side chains, hydrogen bonding between polar groups and water, and hydrophobic hydration. Once salt is added to the mixture, there is an increase in the surface tension of the water, thus increasing hydrophobic interactions between water and the protein of interest. The protein of interest then reduces its surface area, which diminishes its contact with the solvent. This is shown by the folding and self-association, which ultimately leads to precipitation. The folding and self-association of the protein pushes out free water, leading to an increase in entropy and making this process energetically favorable.
Sources: en.wikipedia.org
Circulatory system: pumping and channeling blood to and from the body and lungs with heart, blood, blood vessels Digestive system: digestion and processing food with salivary glands, esophagus, stomach, liver, gallbladder, pancreas, intestines, rectum, anus Endocrine system: communication within the body using hormones made by endocrine glands such as the hypothalamus, pituitary gland, pineal gland, thyroid, parathyroid glands, adrenal glands Immune system: the system that fights off disease; composed of leukocytes, tonsils, adenoids, thymus, spleen Integumentary system: skin, hair, nails Lymphatic system: structures involved in the transfer of lymph between tissues and the blood stream, the lymph and the nodes and vessels that transport it Musculoskeletal system: muscles provide movement and a skeleton provides structural support and protection with bones, cartilage, ligaments, tendons Nervous system: collecting, transferring and processing information with brain, spinal cord, nerves Reproductive system: the sex organs; in the female; ovaries, fallopian tubes, uterus, vagina, mammary glands, and in the male; testicles, vas deferens, seminal vesicles, prostate, penis Respiratory system: the organs used for breathing, the pharynx, larynx, trachea, bronchi, lungs, diaphragm Urinary system: kidneys, ureters, bladder, urethra involved in fluid balance, electrolyte balance, and excretion of urine
The role of electricity in the nervous systems of animals was first observed in dissected frogs by Luigi Galvani, who studied it from 1791 to 1797. Galvani's results inspired Alessandro Volta to develop the Voltaic pile—the earliest-known electric battery—with which he studied animal electricity (such as electric eels) and the physiological responses to applied direct-current voltages. In the 19th century scientists studied the propagation of electrical signals in whole nerves (i.e., bundles of neurons) and demonstrated that nervous tissue was made up of cells, instead of an interconnected network of tubes (a reticulum). Carlo Matteucci followed up Galvani's studies and demonstrated that injured nerves and muscles in frogs could produce direct current. Matteucci's work inspired the German physiologist, Emil du Bois-Reymond, who discovered in 1843 that stimulating these muscle and nerve preparations produced a notable diminution in their resting currents, making him the first researcher to identify the electrical nature of the action potential. The conduction velocity of action potentials was then measured in 1850 by du Bois-Reymond's friend, Hermann von Helmholtz. Progress in electrophysiology stagnated thereafter due to the limitations of chemical theory and experimental practice. To establish that nervous tissue is made up of discrete cells, the Spanish physician Santiago Ramón y Cajal and his students used a stain developed by Camillo Golgi to reveal the myriad shapes of neurons, which they rendered painstakingly.
=== Diplomats === Hamzat Ahmadu - Nigerian diplomat, former ambassador to the Soviet Union, the United States of America and high commissioner to the Bahamas. Nuhu Bamalli - Former minister of foreign affairs Mohammed Sanusi Barkindo – 28th Secretary-General of OPEC. Ibrahim Gambari – (Fulani/Yoruba); Scholar and diplomat; Chief of Staff to the president; Under-Secretary-General / Special Adviser – Africa United Nations; former minister of foreign affairs, current chief of staff to the president of Nigeria. Amina J. Mohammed – (Fulani/English); Politician; Deputy Secretary-General of the United Nations; former Federal Minister of Environment, Nigeria. Tijjani Muhammad-Bande – Political scientist, administrator and career diplomat. Current president of the United Nations General Assembly, Permanent Representative of Nigeria to the UN, former VP of the UN General Assembly. Nura Abba Rimi - Nigeria's ambassador to the Arab Republic of Egypt, with concurrent accreditation to the State of Palestine and the State of Eritrea; former Presidential Liaison Officer. Ibrahim Sulu-Gambari – (Fulani/Yoruba); Nigerian judge and monarch. Current Emir of Ilorin, Nigeria. Yusuf Tuggar – Minister of Foreign Affairs. Aminu Bashir Wali - Former permanent representative to the United Nations, former minister of foreign affairs. Isa Wali - former Nigerian high commissioner to Ghana.
Sources: en.wikipedia.org
=== Impurity === MDDMA is occasionally encountered as an impurity in MDMA which has been synthesized by methylation of MDA using methylating chemical reagents such as methyl iodide. An excess of reagent or a reaction temperature that is too high results in some double methylation of the amine nitrogen, yielding MDDMA as well as MDMA. The presence of MDDMA as an impurity can thus reveal which synthetic route was used to manufacture seized samples of MDMA.
== Bound-state β− decay == A very small minority of free neutron decays (about four per million) are "two-body decays": the proton, electron and antineutrino are produced, but the electron fails to gain the 13.6 eV energy necessary to escape the proton, and therefore simply remains bound to it, as a neutral hydrogen atom. In this type of beta decay, in essence all of the neutron decay energy is carried off by the antineutrino. For fully ionized atoms (bare nuclei), it is possible in likewise manner for electrons to fail to escape the atom, and to be emitted from the nucleus into low-lying atomic bound states (orbitals). This can in theory occur for neutral atoms, as a new bound state is always opened by the decay, but rarely is appreciable. Bound-state β− decays were predicted by Daudel, Jean, and Lecoin in 1947, and the phenomenon in fully ionized atoms was first observed for 163Dy66+ in 1992 by Jung et al. of the Darmstadt Heavy-Ion Research Center. Though neutral 163Dy is stable, fully ionized 163Dy66+ undergoes β− decay into the K and L shells with a half-life of 47 days. The resulting nucleus – 163Ho66+ – is stable only in this almost fully ionized state and will decay via electron capture back into 163Dy in the neutral state. Likewise, while being stable in the neutral state, the fully ionized 205Tl81+ undergoes bound-state β− decay to 205Pb81+ with a half-life of 291+33−27 days. The half-lives of neutral 163Ho and 205Pb are respectively 4570 years and 1.70×107 years. The Q-value of bound-state beta decay of a highly-ionized atom,
Beyond its store endeavors, Jollibee also ventured into media, notably partnering with GMA for the children's magazine show Chikiting Patrol, which aired from 1996 to 2002. In 1998, Jollibee would expand to North America with its first United States location in Daly City, California. Jollibee first entered Europe in 2018 with the opening of a branch in Milan, Italy.
Military submarines use several systems to communicate with distant command centers or other ships. One is VLF (very low frequency) radio, which can reach a submarine either on the surface or submerged to a fairly shallow depth, usually less than 250 feet (76 m). ELF (extremely low frequency) can reach a submarine at greater depths, but has a very low bandwidth and is generally used to call a submerged sub to a shallower depth where VLF signals can reach. A submarine also has the option of floating a long, buoyant wire antenna to a shallower depth, allowing VLF transmissions by a deeply submerged boat. By extending a radio mast, a submarine can also use a "burst transmission" technique. A burst transmission takes only a fraction of a second, minimizing a submarine's risk of detection. To communicate with other submarines, a system known as Gertrude is used. Gertrude is basically a sonar telephone. Voice communication from one submarine is transmitted by low power speakers into the water, where it is detected by passive sonars on the receiving submarine. The range of this system is probably very short, and using it radiates sound into the water, which can be heard by the enemy. Civilian submarines can use similar, albeit less powerful systems to communicate with support ships or other submersibles in the area.
Sources: en.wikipedia.org
Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.
No, cardarine is not a steroid. It is classified as a PPARδ agonist. Its structure and receptor target differ from anabolic steroids.
No regulatory agency has approved cardarine as a medicine. It was investigated in early research but development was discontinued. It is not available as a prescription drug.
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.